Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.

Atrys HealthAtrys

  • Español
  • English

Main navigation

  • Company
    • Presentation
    • Mission, vision and values
  • Laboratory
    • Laboratory
    • Test directory
    • Clinical trials and R&D services
    • Quality
    • Team
  • Telemedecine
    • What is telemedicine?
    • Radiology
    • Cardiology Cardiology
    • Ophthalmology
    • Dermatology
  • Radiotherapy
  • R&D
    • R&D
    • LIQUID BIOPSY
    • PROGNOSTIC ALGORITHMS
    • DATA INTEGRATION PLATFORMS
    • ONLINE DIAGNOSIS
    • OTHER PROJECTS
    • R&D services and training agreements
    • Publications and patents
  • Investors
    • Investors area
    • Shares
    • Financial information
    • Analysts coverage
    • Corporate governance
  • News
  • Contact
    • Work with us

    • Private area

  • Español
  • English
  • Company
    • Presentation
    • Mission, vision and values
  • Laboratory
    • Laboratory
    • Test directory
      • Anatomic Pathology
      • Cytology
      • Hematology
      • Diagnostic Second Opinion
    • Clinical trials and R&D services
    • Quality
    • Team
  • Telemedecine
    • What is telemedicine?
    • Radiology
    • Cardiology Cardiology
    • Ophthalmology
    • Dermatology
  • Radiotherapy
  • R&D
    • R&D
    • LIQUID BIOPSY
      • PS100P
      • Surveprost
      • Aptalung
      • InmunoSIGHT
      • Oncoporecise
      • Glibioliquid
      • Metabreast
    • PROGNOSTIC ALGORITHMS
      • 3TR
      • Predictgyn
      • Tradion P
      • Anxarecu
      • Precisesads
      • Oncoexpert
      • Prostatepredict
      • IHC and FISH study of EGFRvIII and PTEN expression in relapsed high grade gliomas
      • Identification of a predictive model for therapeutic guidance in cerebral tumors (gliomas) by means of systems pathology
      • Identificación de un modelo predictivo de opción terapéutica en cáncer de mama mediante la aplicación de la Patología Molecular y de Sistemas
      • Identificación de un modelo predictivo de opción terapéutica en linfomas de célula grande (DLBCL) mediante la aplicación de Patología de Sistemas
    • DATA INTEGRATION PLATFORMS
      • Plataforma de ayuda a la detección temprana de enfermedades infecciosas, mediante la identificación local de patógenos a partir de resultados de analíticas provenientes de laboratorios de análisis mediante técnicas de big data y hacking ético
    • ONLINE DIAGNOSIS
      • Daplia
      • eDCardio
      • eDSalud
      • eHealth areas in Hotels
    • OTHER PROJECTS
      • TheraYAP
      • Gliomatherapy
      • Papiloma
      • Zitomab
      • System of pharmacogenomic evaluation for breast cancer treatment with aromatase inhibitors according to a new application designed by ROVI Laboratories
    • R&D services and training agreements
    • Publications and patents
      • Methods for prognosis of diffuse large b-cell lymphoma
      • EGFR and PTEN gene alterations predicts survival in patients with brain tumors
      • Monoclonal antibodies for the diagnosis, treatment and/or prevention of brain tumors and brain lesions
  • Investors
    • Investors area
    • Shares
    • Financial information
    • Analysts coverage
    • Corporate governance
  • News
  • Contact
    • Work with us

Private area

MAB - Mercado Alternativo Bursátil

Research and development

  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents

Research Projects

The projects grouped in this section aim to develop PROGNOSTIC ALGORITHMS based on the expression of different biomarkers.

SP100P
  • 3TR
3TR
  • Surveprost
SURVEPROST
  • Aptalung
APTALUNG
  • InmunoSIGHT
InmunoSIGHT
  • Brain
GLIBIOLIQUID
  • TheraYAp
TheraYAP
  • Gliomatherapy
GLIOMATHERAPY
PREDICTGYN
ANXARECU
PRECISESADS
PROSTATEPREDICT
  • Oncoexpert
ONCOEXPERT
  • Tradion P
TRADION P
  • Estudio mediante inmunohistoquímica e hibridación in situ fluorescente (FISH) de la expresión de EGFRvIII y PTEN en gliomas recidivantes de alto grado
EGFRvIII & PTEN in GBM
  • Identificación de un modelo predictivo de opción terapéutica en cáncer de mama mediante la aplicación de la Patología Molecular y de Sistemas
PREDICTIVE MODELS IN BREAST CANCER
  • Identificación de un modelo predictivo de opción terapéutica en linfomas de célula grande (DLBCL) mediante la aplicación de Patología de Sistemas
DLBCL - PREDICTIVE MODEL
  • Identificación de un modelo predictivo de opción terapéutica en tumores cerebrales (gliomas) mediante la aplicación de Patología de Sistemas.
GBM - PREDICTIVE MODEL
  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
Atrys logo

Atrys Barcelona

C/Provença 392, planta baixa, 
08025, Barcelona

T: +34 934 815 561

info@atryshealth.com

Atrys Madrid

C/ Velázquez 24, 4ºIzq
28001 Madrid

T: +34 917 819 465

info@atryshealth.com

Atrys Granada

Edificio Genyo (PTCS)

Av. Ilustración 114 
18007  Granada

T: +34 958 715 500, ext. 125

info@atryshealth.com

 

 

Web design | Legal advice